Exelixis | EXEL - 시가 총액

주가
41.09
매일 변경
-0.15 -0.36%
매월
-6.78%
매년
10.99%
Q1 예상
39.99




시가 총액 변화 날짜
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 502M 75M 2025-03
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bayer EUR 36.89B 535.42M 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Exelixis USD 11.75B 959M 2025-12
Genmab DKK 80.88B 7.82B 2025-06
Glaxosmithkline GBP 86.88B 7.29B 2025-09
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
MacroGenics USD 106M 29M 2025-09
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 265.66B 9.48B 2025-09
Pfizer USD 141.57B 6.48B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Xencor USD 1.09B 256M 2025-12